|
TNPO1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.485800005252E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.84480053034531E-10 |
| Normal-vs-Stage2 |
3.738300E-02 |
| Normal-vs-Stage3 |
3.866300E-02 |
| Normal-vs-Stage4 |
1.102620E-01 |
| Stage1-vs-Stage2 |
8.627800E-02 |
| Stage1-vs-Stage3 |
3.452100E-02 |
| Stage1-vs-Stage4 |
2.180000E-01 |
| Stage2-vs-Stage3 |
9.001600E-01 |
| Stage2-vs-Stage4 |
9.620800E-01 |
| Stage3-vs-Stage4 |
8.833000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.42990000027299E-09 |
| Normal-vs-AfricanAmerican |
1.20969999994891E-06 |
| Normal-vs-Asian |
3.064400E-01 |
| Caucasian-vs-AfricanAmerican |
9.234600E-01 |
| Caucasian-vs-Asian |
3.851400E-01 |
| AfricanAmerican-vs-Asian |
4.249000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.47350045895689E-10 |
| Normal-vs-Female |
2.073600E-02 |
| Male-vs-Female |
4.202200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.763320E-03 |
| Normal-vs-Extreme_Weight |
1.08569819801119E-11 |
| Normal-vs-Obese |
4.09070000000344E-05 |
| Normal-vs-Extreme_Obese |
1.027180E-04 |
| Normal_Weight-vs-Extreme_Weight |
7.862200E-02 |
| Normal_Weight-vs-Obese |
9.984000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.383000E-01 |
| Extreme_Weight-vs-Obese |
1.381950E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.887000E-01 |
| Obese-vs-Extreme_Obese |
5.067800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.977800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.61259999997831E-06 |
| Normal-vs-Age(61-80Yrs) |
5.46759970632138E-10 |
| Normal-vs-Age(81-100Yrs) |
6.09579999999443E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.119600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.115600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.292800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.172100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.871000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.471400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.32658337040448E-12 |
| Normal-VS-Type2 PRCC |
3.644900E-03 |
| Normal-VS-KIRP CIMP |
5.345800E-01 |
| Normal-VS-Unclassified PRCC |
6.139200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.120000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
8.165000E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.091710E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.298600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.161800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.363000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.00140000003357E-06 |
| Normal-vs-N1 |
1.413770E-01 |
| Normal-vs-N2 |
1.062420E-01 |
| N0-vs-N1 |
4.404400E-02 |
| N0-vs-N2 |
5.506800E-01 |
| N1-vs-N2 |
7.259000E-01 |
|
|
